US · Healthcare

Liquidia Technologies Inc (LQDA)

Drug Manufacturers - Specialty & Generic

Liquidia Technologies Inc (LQDA) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for LQDA

P/E ratio

18.00

Liquidia Technologies Inc (LQDA) — FAQ

What is LQDA's P/E ratio?

The price-to-earnings (P/E) ratio for Liquidia Technologies Inc (LQDA) is 18.00 (data as of 2026-03-24).

Does Liquidia Technologies Inc pay a dividend?

Dividend yield is not available in the current snapshot for Liquidia Technologies Inc (LQDA). Check the MyAverix Finance app for the latest dividend data.

What sector is Liquidia Technologies Inc in?

Liquidia Technologies Inc (LQDA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is LQDA listed on?

LQDA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)